We are live on ! Find out more
QTTB icon

Q32 Bio

87 hedge funds and large institutions have $49.9M invested in Q32 Bio in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 20 increasing their positions, 28 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.4% less ownership

Funds ownership: 2.85%2.45% (-0.4%)

18% less funds holding

Funds holding: 10687 (-19)

29% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 28

44% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 34

44% less capital invested

Capital invested by funds: $89.6M → $49.9M (-$39.7M)

97% less call options, than puts

Call options by funds: $36K | Put options by funds: $1.1M

Holders
87
Holders Change
-19
Holders Change %
-17.92%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
19
Increased
20
Reduced
28
Closed
34
Calls
$36K
Puts
$1.1M
Net Calls
-$1.07M
Net Calls Change
+$2.25M
Name Holding Trade Value Shares
Change
Change in
Stake
B
51
Bailard
California
$47K +$45K +1,319 New
Marshall Wace
52
Marshall Wace
United Kingdom
$42K +$40.8K +1,194 New
Assenagon Asset Management
53
Assenagon Asset Management
Luxembourg
$40K +$38.2K +1,119 New
Bank of New York Mellon
54
Bank of New York Mellon
New York
$38K -$257K -7,542 -87%
HSBC Holdings
55
HSBC Holdings
United Kingdom
$35K -$376 -11 -1%
VF
56
Virtu Financial
New York
$34K +$32.9K +965 New
RJA
57
Raymond James & Associates
Florida
$33K
DCM
58
Dimension Capital Management
Florida
$32K
LP
59
LMR Partners
United Kingdom
$29K +$28.4K +831 New
HF
60
HRT Financial
New York
$28K +$27.3K +800 New
Balyasny Asset Management
61
Balyasny Asset Management
Illinois
$23K +$22.6K +662 New
Verition Fund Management
62
Verition Fund Management
Connecticut
$21K +$20K +586 New
Commonwealth Equity Services
63
Commonwealth Equity Services
Massachusetts
$20K -$5.16K -151 -20%
TYCC
64
Texas Yale Capital Corp
Florida
$20K
Rockefeller Capital Management
65
Rockefeller Capital Management
New York
$20K +$376 +11 +2%
Lazard Asset Management
66
Lazard Asset Management
New York
$17K +$580 +17 +3%
TRCT
67
Tower Research Capital (TRC)
New York
$14K +$6.96K +204 +111%
CC
68
Cannell Capital
Wyoming
$11K +$10.9K +320 New
Legal & General Group
69
Legal & General Group
United Kingdom
$7K -$58.5K -1,714 -90%
Wells Fargo
70
Wells Fargo
California
$4K -$115K -3,365 -97%
US Bancorp
71
US Bancorp
Minnesota
$4K -$7.75K -227 -69%
EWM
72
Endurance Wealth Management
Rhode Island
$4K
CAPTRUST Financial Advisors
73
CAPTRUST Financial Advisors
North Carolina
$3K +$376 +11 +16%
Royal Bank of Canada
74
Royal Bank of Canada
Ontario, Canada
$2K -$7.17K -210 -77%
Osaic Holdings
75
Osaic Holdings
Arizona
$2K -$6.83K -200 -79%

QTTB Hedge Fund Activity: Q2 2022 in Review

87 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q2 2022, worth a combined $49.9M — down 44% from $89.6M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of QTTB and 19 opened new positions — a net loss of 15 holders — while 28 trimmed existing stakes and 20 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $1.37M. The largest seller was BlackRock, cutting an estimated $4.2M.

  • 87 institutional investors held Q32 Bio (QTTB) as of Q2 2022, down from 106 in Q1 2022.
  • Funds reported $49.9M of Q32 Bio stock for Q2 2022, down 44% quarter-over-quarter.
  • 19 funds opened new Q32 Bio positions in Q2 2022 and 34 closed out, a net change of -15 holders.
  • The largest Q32 Bio buyer in Q2 2022 was Millennium Management, an estimated $1.37M added.
  • The largest Q32 Bio seller in Q2 2022 was BlackRock, an estimated $4.2M sold.

Based on aggregated 13F filings for Q2 2022.